Journal of Clinical Medicine, Volume 7, Issue 11
2018 November - 86 articles
Cover Story: The liver transplantation following donation after cardiac death (DCD) has been receded by the high risks of dispiriting outcomes like biliary complications, hepatic artery thrombosis and primary nonfunction. The reasons behind increased susceptibility to DCD livers are lucid, however, plausible explanations suggest that the microthrombi formation and disruption of biliary ductal microcirculation secondary to obligatory acirculatory phase. The administration of a thrombolytic agent (thrombolytic flush), tissue plasminogen activator (tPA), into the hepatic artery prior to reperfusion dissolve any potential microthrombi in the biliary microcirculation and thereby mitigate the occurrence of these complications. However, the implications of this novel concept in the liver transplantation following DCD livers are yet to be fully explored. View this paper. - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.